ArticleMolecular cancer therapeutics2026

An Integrin β6-Targeted Antibody-Drug Conjugate Optimized for Intravesical Delivery to Treat Non-Muscle-Invasive Bladder Cancer.

Christopher M Carosino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.